Page 104 - GTM-2-3
P. 104
Global Translational Medicine Autoimmune diseases after vaccination
https://doi.org/10.1007/s12026-014-8575-3 lupus erythematosus and thrombocytopenic purpura in two
members of the same family following hepatitis B vaccine.
38. Mehlsen J, Brinth L, Pors K, et al., 2022, Autoimmunity in
patients reporting long-term complications after exposure Nephrol Dial Transplant, 13: 2420–2421.
to human papilloma virus vaccination. J Autoimmun, https://doi.org/10.1093/ndt/13.9.2420
133: 102921.
49. Blumenthal D, Prais D, Bron-Harlev E, et al., 2004, Possible
https://doi.org/10.1016/j.jaut.2022.102921 association of Guillain-Barré syndrome and hepatitis A
vaccination. Pediatr Infect Dis J, 23: 586–588.
39. CDC, 2023, Vaccine Excipient Summary. Available from: https://
www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/b/ https://doi.org/10.1097/01.inf.0000130941.72712.33
excipient-table-2.pdf [Last accessed on 2023 Aug 08].
50. Tourbah A, Gout O, Liblau R, et al., 1999, Encephalitis after
40. Geier DA, Geier MR, 2005, A case-control study of hepatitis B vaccination: Recurrent disseminated encephalitis
serious autoimmune adverse events following hepatitis B or MS? Neurology, 53: 396–401.
immunization. Autoimmunity, 38: 295–301.
https://doi.org/10.1212/WNL.53.2.396
https://doi.org/10.1080/08916930500144484
51. Pordeus V, Szyper-Kravitz M, Levy RA, et al., 2008,
41. Gross K, Combe C, Krüger K, et al., 1995, Arthritis after Infections and autoimmunity: A panorama. Clin Rev Allergy
hepatitis B vaccination. Report of three cases. Scand J Immunol, 34: 283–299.
Rheumatol, 24: 50–52.
https://doi.org/10.1007/s12016-007-8048-8
https://doi.org/10.3109/03009749509095156
52. Ricke DO, 2021, Two different antibody-dependent
42. Rahimi SS, Ostrov BE, Lopez-Pena M, 2021, Inflammatory enhancement (ADE) risks for SARS-CoV-2 antibodies.
arthritis following hepatitis B vaccination in an infant. Case Front Immunol, 12: 640093.
Rep Rheumatol, 2021: 5598217.
https://doi.org/10.3389/fimmu.2021.640093
https://doi.org/10.1155/2021/5598217
53. Ricke DO, 2021, Etiology scenarios for multisystem
43. Wise RP, Kiminyo KP, Salive ME, 1997, Hair loss after inflammatory syndrome in children and adults associated
routine immunizations. JAMA, 278: 1176–1178. with SARS-CoV-2. J Integr Pediatr Healthc, 3: 1–5.
https://doi.org/10.1001/jama.1997.03550140068042 54. Liang Y, Meng FY, Pan HF, et al., 2015, A literature review on
the patients with autoimmune diseases following vaccination
44. Erguven M, Guven S, Akyuz U, et al., 2009, Optic neuritis
following hepatitis B vaccination in a 9-year-old girl. J Chin against infections. Hum Vaccin Immunother, 11: 2274–2280.
Med Assoc, 72: 594–597. https://doi.org/10.1080/21645515.2015.1009337
https://doi.org/10.1016/S1726-4901(09)70435-6 55. Frasca L, Ocone G, Palazzo R, 2023, Safety of COVID-19
vaccines in patients with autoimmune diseases, in patients
45. Sudarshan S, Huang EH, Lim PL, et al., 2012, A case of post-
vaccination optic neuritis: Coincidence or causative? Eye with cardiac issues, and in the healthy population. Pathogens,
(Lond), 26: 1498. 12: 223.
https://doi.org/10.3390/pathogens12020233
https://doi.org/10.1038/eye.2012.146
56. Ferri C, Ursini F, Gragnani L, et al., 2021, Impaired
46. Cockwell P, Allen MB, Page R, 1990, Vasculitis related to
hepatitis B vaccine. BMJ, 301: 1281. immunogenicity to COVID-19 vaccines in autoimmune
systemic diseases. High prevalence of non-response in
https://doi.org/10.1136/bmj.301.6763.1281-b different patients’ subgroups. J Autoimmun, 125: 102744.
47. Awad MH, El-Hawary A, Sawah G, et al., 2021, Pan-vasculitis https://doi.org/10.1016/j.jaut.2021.102744
and fulminant hepatitis following routine vaccination at the
age of 4 months. Clin Exp Vaccine Res, 10: 78–80. 57. Efe C, Taşçılar K, Gerussi A, et al., 2022, SARS-CoV-2
vaccination and risk of severe COVID-19 outcomes in patients
https://doi.org/10.7774/cevr.2021.10.1.78 with autoimmune hepatitis. J Autoimmun, 132: 102906.
48. Finielz P, Lam-Kam-Sang LF, Guiserix J, 1998, Systemic https://doi.org/10.1016/j.jaut.2022.102906
Volume 2 Issue 3 (2023) 11 https://doi.org/10.36922/gtm.1455

